AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC

There is no fulltext present in this item.

Title:	AKT inhibition as a strategy for targeting hypoxic HPV-positive HNSCC
Author(s):	Göttgens, E.L.; Bussink, J. ; Ansems, M. ; Hammond, E.M.; Span, P.N.
Publication year:	2020
Source:	Radiotherapy and Oncology, vol. 149, (2020), pp. 1-7
ISSN:	0167-8140
DOI:	https://doi.org/10.1016/j.radonc.2020.04.048
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/222052
Display more details
Subject:	All institutes and research themes of the Radboud University Medical Center Radboudumc 17: Women's cancers RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization:	Radiation Oncology Laboratory Medicine
Journal title:	Radiotherapy and Oncology
Volume:	vol. 149
Page start:	p. 1
Page end:	p. 7